Identification of Thiostrepton as a Novel Inhibitor for Psoriasis-like Inflammation Induced by TLR7–9

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Immunology

• Publication date

  2015-09-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1500194PMID 26371257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokines as therapeutic targets in skin inflammation.

  2014cited by this paper
• Bortezomib in multiple myeloma: systematic review and clinical considerations.

  2014cited by this paper
• Treatment of systemic lupus erythematosus: new therapeutic avenues and blind alleys

  2014cited by this paper
• Targeting Dendritic Cell Function during Systemic Autoimmunity to Restore Tolerance

  2014cited by this paper
• TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.

  2014cited by this paper
• Interplay between CXCR2 and BLT1 Facilitates Neutrophil Infiltration and Resultant Keratinocyte Activation in a Murine Model of Imiquimod-Induced Psoriasis

  2014cited by this paper
• An improved flow cytometry assay to monitor phagosome acidification.

  2014cited by this paper
• Assembly and localization of Toll-like receptor signalling complexes

  2014cited by this paper
• Immunology of psoriasis.

  2014cited by this paper
• The pathophysiological role of dendritic cell subsets in psoriasis

  2014cited by this paper
• Thiostrepton, a natural compound that triggers heat shock response and apoptosis in human cancer cells: a proteomics investigation.

  2014cited by this paper
• Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy

  2014cited by this paper
• Linking the activity of bortezomib in multiple myeloma and autoimmune diseases.

  2014cited by this paper
• Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases.

  2013cited by this paper
• Nucleic acids and endosomal pattern recognition: how to tell friend from foe?

  2013cited by this paper
• Curcumin Inhibits Imiquimod-Induced Psoriasis-Like Inflammation by Inhibiting IL-1beta and IL-6 Production in Mice

  2013cited by this paper
• Parthenolide: from plant shoots to cancer roots.

  2013cited by this paper
• Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin Inflammation

  2013influential reference
• Phenoxybenzamine in Complex Regional Pain Syndrome: Potential Role and Novel Mechanisms

  2013cited by this paper
• The role of dendritic cells in autoimmunity

  2013cited by this paper
• Targeting Toll-like receptors with small molecule agents.

  2013cited by this paper
• This information is current as Dendritic Cells Psoriasis by Restricting MyD 88 Signals in Cutting Edge : ABIN-1 Protects against

  2013cited by this paper
• Faculty Opinions recommendation of Cutting edge: ABIN-1 protects against psoriasis by restricting MyD88 signals in dendritic cells.

  2013cited by this paper
• Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs.

  2012cited by this paper
• Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.

  2012cited by this paper
• Therapeutic Applications of Nucleic Acids and Their Analogues in Toll-like Receptor Signaling

  2012cited by this paper
• Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37.

  2012cited by this paper
• Proteasome inhibitors: a new perspective for treating autoimmune diseases.

  2012cited by this paper
• Structural biology of the Toll-like receptor family.

  2011cited by this paper
• Novel IκB kinase inhibitors for treatment of nuclear factor-κB-related diseases

  2011cited by this paper
• Endosome maturation

  2011cited by this paper
• Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis.

  2011cited by this paper
• 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling.

  2011cited by this paper
• Functional interaction of heat shock protein 90 and Beclin 1 modulates Toll‐like receptor‐mediated autophagy

  2011cited by this paper
• Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.

  2011cited by this paper
• Thiostrepton, proteasome inhibitors and FOXM1

  2011cited by this paper
• Vacuolar H(+)-ATPases: intra- and intermolecular interactions.

  2011cited by this paper
• Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands

  2011cited by this paper
• Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines

  2011cited by this paper
• CD8+, CD8-, and plasmacytoid dendritic cell generation in vitro using flt3 ligand.

  2010influential reference
• A five-amino-acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition.

  2010cited by this paper
• Mechanisms regulating dendritic cell specification and development

  2010influential reference
• Intracellular toll-like receptors.

  2010cited by this paper
• Localisation and trafficking of Toll-like receptors: an important mode of regulation.

  2010cited by this paper
• Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8

  2009cited by this paper
• Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.

  2009cited by this paper
• Variation matters: TLR structure and species-specific pathogen recognition.

  2009cited by this paper
• Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9.

  2008cited by this paper
• Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression

  2008cited by this paper
• Development of TLR inhibitors for the treatment of autoimmune diseases

  2008cited by this paper
• Structures of the toll-like receptor family and its ligand complexes.

  2008cited by this paper
• Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

  2007cited by this paper
• Signaling pathways downstream of pattern-recognition receptors and their cross talk.

  2007cited by this paper
• The Connectivity Map: a new tool for biomedical research

  2007cited by this paper
• The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

  2007cited by this paper
• The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

  2006cited by this paper
• TLR signaling

  2006cited by this paper
• IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

  2006influential reference
• Recognition and signaling by toll-like receptors.

  2006cited by this paper
• TLR signaling.

  2006cited by this paper
• Toll-like receptors: linking innate and adaptive immunity.

  2005cited by this paper
• Toll-like receptors: linking innate and adaptive immunity.

  2004cited by this paper
• Innate immune responses to microbial poisons: discovery and function of the Toll-like receptors.

  2003cited by this paper
• Dendritic cells and host resistance to infection

  2003cited by this paper
• Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily.

  2002cited by this paper
• A universal role for MyD88 in TLR/IL-1R-mediated signaling.

  2002cited by this paper
• Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells.

  2001cited by this paper
• Proteasome inhibitors: from research tools to drug candidates.

  2001cited by this paper
• Toll receptors in innate immunity.

  2001cited by this paper
• Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.

  2000cited by this paper
• The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB).

  2000cited by this paper

• Dissecting the role of imiquimod and isostearic acid in Aldara-induced psoriasis mouse model.

  2026cites this paper
• Discovery of selective TLR9 antagonists via machine learning-driven structural modeling and experimental validation.

  2025cites this paper
• Discovery of ETI41 and ETI60: novel selective endosomal Toll-like receptor inhibitors for the treatment of autoimmune diseases

  2025cites this paper
• Rational design and therapeutic potential of MyD88 inhibitory peptide in psoriasis.

  2025cites this paper
• Exploration of the Pathogenicity and Inflammatory Mechanism of Wuxiang Virus: A Newly Identified Phlebovirus

  2025cites this paper
• Emerging Therapeutic Agents and Nanotechnology-Driven Innovations in Psoriasis Management.

  2025cites this paper
• Thiostrepton: multifaceted biological activities and its applications in treatment of inflammatory diseases

  2024influential citation
• Procyanidin B2 3,3''-di-O-gallate ameliorates imiquimod-induced skin inflammation by suppressing TLR7 signaling through the inhibition of endosomal acidification in dendritic cells.

  2023cites this paper
• Thiostrepton alleviates experimental colitis by promoting RORγt ubiquitination and modulating dysbiosis

  2023cites this paper
• Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice

  2023cites this paper
• Immunomodulation, Bioavailability and Safety of Bacteriocins

  2023cites this paper
• Microbial derived antimicrobial peptides as potential therapeutics in atopic dermatitis

  2023cites this paper
• Mechanism of Action of Ribosomally Synthesized and Post-Translationally Modified Peptides.

  2022cites this paper
• Chemical reagents modulate nucleic acid-activated toll-like receptors.

  2022cites this paper
• The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications.

  2021cites this paper
• Introduction to Thiopeptides: Biological Activity, Biosynthesis, and Strategies for Functional Reprogramming.

  2020cites this paper
• Gene expression profile analysis of the rabbit retinal vein occlusion model

  2020cites this paper
• RNA Modifications Modulate Activation of Innate Toll-Like Receptors

  2019cites this paper
• Development of co-solvent freeze-drying method for the encapsulation of water-insoluble thiostrepton in sterically stabilized micelles.

  2019cites this paper
• A novel technique to diagnose non‐melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors

  2019cites this paper
• Identification of thiostrepton as a pharmacological approach to rescue misfolded alpha-sarcoglycan mutant proteins from degradation

  2019cites this paper
• Involvement of M1 Macrophage Polarization in Endosomal Toll-Like Receptors Activated Psoriatic Inflammation

  2018cites this paper
• The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials

  2018cites this paper
• Natural Modulators of Endosomal Toll-Like Receptor-Mediated Psoriatic Skin Inflammation

  2017cites this paper
• IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.

  2017cites this paper
• Localization of nucleic acid‐sensing toll‐like receptors in human and mouse pancreas

  2017cites this paper
• Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice

  2017cites this paper
• Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.

  2016cites this paper